share_log

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4:持股變動聲明-董事 Farley Chele Chiavacci
美股SEC公告 ·  11/21 05:33

牛牛AI助理已提取核心訊息

Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, completed a purchase of 299,238 shares of common stock on November 18, 2024. The transaction was carried out at a price of $0.0919 per share, resulting in a total investment of approximately $27,489. The acquisition was made directly and increased Chiavacci's total holdings in the company to 351,510 shares. This transaction reflects a significant buy-in by Chiavacci, signaling potential confidence in the future of Conduit Pharmaceuticals.
Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, completed a purchase of 299,238 shares of common stock on November 18, 2024. The transaction was carried out at a price of $0.0919 per share, resulting in a total investment of approximately $27,489. The acquisition was made directly and increased Chiavacci's total holdings in the company to 351,510 shares. This transaction reflects a significant buy-in by Chiavacci, signaling potential confidence in the future of Conduit Pharmaceuticals.
Farley Chele Chiavacci,與Conduit Pharmaceuticals有關,於2024年11月18日完成了299,238股普通股的購買。該交易以每股0.0919美元的價格進行,總投資約爲27,489美元。這次收購是直接進行的,將Chiavacci在公司中的總持股增加到351,510股。這筆交易反映出Chiavacci的重大買入,表明Chiavacci對Conduit Pharmaceuticals未來的信心。
Farley Chele Chiavacci,與Conduit Pharmaceuticals有關,於2024年11月18日完成了299,238股普通股的購買。該交易以每股0.0919美元的價格進行,總投資約爲27,489美元。這次收購是直接進行的,將Chiavacci在公司中的總持股增加到351,510股。這筆交易反映出Chiavacci的重大買入,表明Chiavacci對Conduit Pharmaceuticals未來的信心。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。